212 related articles for article (PubMed ID: 1528208)
1. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer.
Prandoni P; Lensing AW; Büller HR; Cogo A; Prins MH; Cattelan AM; Cuppini S; Noventa F; ten Cate JW
N Engl J Med; 1992 Oct; 327(16):1128-33. PubMed ID: 1528208
[TBL] [Abstract][Full Text] [Related]
2. The occurrence of subsequent malignancy in patients presenting with deep vein thrombosis: results from a historical cohort study.
Rajan R; Levine M; Gent M; Hirsh J; Geerts W; Skingley P; Julian J
Thromb Haemost; 1998 Jan; 79(1):19-22. PubMed ID: 9459315
[TBL] [Abstract][Full Text] [Related]
3. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W;
N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010
[TBL] [Abstract][Full Text] [Related]
4. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.
Schulman S; Lindmarker P
N Engl J Med; 2000 Jun; 342(26):1953-8. PubMed ID: 10874063
[TBL] [Abstract][Full Text] [Related]
5. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism.
Sørensen HT; Mellemkjaer L; Steffensen FH; Olsen JH; Nielsen GL
N Engl J Med; 1998 Apr; 338(17):1169-73. PubMed ID: 9554856
[TBL] [Abstract][Full Text] [Related]
6. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).
Simioni P; Prandoni P; Lensing AW; Scudeller A; Sardella C; Prins MH; Villalta S; Dazzi F; Girolami A
N Engl J Med; 1997 Feb; 336(6):399-403. PubMed ID: 9010145
[TBL] [Abstract][Full Text] [Related]
7. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.
Prandoni P; Villalta S; Bagatella P; Rossi L; Marchiori A; Piccioli A; Bernardi E; Girolami B; Simioni P; Girolami A
Haematologica; 1997; 82(4):423-8. PubMed ID: 9299855
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of cancers associated with venous thromboembolism.
Sørensen HT; Mellemkjaer L; Olsen JH; Baron JA
N Engl J Med; 2000 Dec; 343(25):1846-50. PubMed ID: 11117976
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of deep-vein thrombosis.
Beyth RJ; Cohen AM; Landefeld CS
Arch Intern Med; 1995 May; 155(10):1031-7. PubMed ID: 7748045
[TBL] [Abstract][Full Text] [Related]
10. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.
Decousus H; Leizorovicz A; Parent F; Page Y; Tardy B; Girard P; Laporte S; Faivre R; Charbonnier B; Barral FG; Huet Y; Simonneau G
N Engl J Med; 1998 Feb; 338(7):409-15. PubMed ID: 9459643
[TBL] [Abstract][Full Text] [Related]
11. Electronic alerts to prevent venous thromboembolism among hospitalized patients.
Kucher N; Koo S; Quiroz R; Cooper JM; Paterno MD; Soukonnikov B; Goldhaber SZ
N Engl J Med; 2005 Mar; 352(10):969-77. PubMed ID: 15758007
[TBL] [Abstract][Full Text] [Related]
12. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.
Kyrle PA; Minar E; Hirschl M; Bialonczyk C; Stain M; Schneider B; Weltermann A; Speiser W; Lechner K; Eichinger S
N Engl J Med; 2000 Aug; 343(7):457-62. PubMed ID: 10950667
[TBL] [Abstract][Full Text] [Related]
13. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
[TBL] [Abstract][Full Text] [Related]
14. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology.
Cushman M; Tsai AW; White RH; Heckbert SR; Rosamond WD; Enright P; Folsom AR
Am J Med; 2004 Jul; 117(1):19-25. PubMed ID: 15210384
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of venous thromboembolism after major trauma.
Geerts WH; Code KI; Jay RM; Chen E; Szalai JP
N Engl J Med; 1994 Dec; 331(24):1601-6. PubMed ID: 7969340
[TBL] [Abstract][Full Text] [Related]
16. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA
N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183
[TBL] [Abstract][Full Text] [Related]
17. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
18. [Deep venous thrombosis and neoplastic pathology: our experience in emergencies].
Schillaci F; Stagnitti F; Iurato C; Mongardini M; Dall'olio D; Salvi PF; Cazzaniga M; Bresadola L; Schultze W; Natalini E
G Chir; 1998; 19(6-7):293-300. PubMed ID: 9707837
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
Lee AY; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Julian JA; Haley S; Kovacs MJ; Gent M;
N Engl J Med; 2003 Jul; 349(2):146-53. PubMed ID: 12853587
[TBL] [Abstract][Full Text] [Related]
20. Preoperative plasma D-dimer is a predictor of postoperative deep venous thrombosis in colorectal cancer patients: a clinical, prospective cohort study with one-year follow-up.
Stender MT; Frøkjaer JB; Larsen TB; Lundbye-Christensen S; Thorlacius-Ussing O
Dis Colon Rectum; 2009 Mar; 52(3):446-51. PubMed ID: 19333044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
